Diversified Effects of Bile Contamination, Postoperative Infections, and Antimicrobial Resistance Level on the Oncologic Prognosis after Pancreatoduodenectomy for Ductal Adenocarcinoma

Luca Gianotti*, Kim C. Honselmann, Marco Angrisani, Francesca Gavazzi, Tobias Keck, Ulrich Wellner, Louisa Bolm, Natalie Petruch, Giovanni Capretti, Gennaro Nappo, Davide P. Bernasconi, Marta Sandini, Alessandro Zerbi

*Corresponding author for this work
1 Citation (Scopus)


Background/Aim: Whether the presence of bacteria in the bile or postoperative infections sustained by microorganisms with different levels of drug-resistance are associated with changes in the oncologic prognosis of patients undergoing surgery for pancreatic cancer has not been thoroughly investigated. The aim was to study the association of bile contamination, postoperative infections, and multi-level resistance with long-term outcome. Patients and Methods: Prospectively maintained databases were queried for patients who underwent pancreatoduodenectomy (PD). Patients who underwent preoperative biliary stenting prior to PD and an intraoperative bile culture were included. The levels of bacterial resistance of intraoperative bile cultures and of specimens of postoperative infections were stratified into multidrug sensitive (MDS), multidrug-resistant (MDR), and extensive drug-resistant (XDR). Results: A total of 267 patients met the inclusion criteria. The Kaplan–Meier survival curves for overall survival (OS) of patients having no bacteriobilia or positive cultures with MDS versus MDR/XDR bacteria were not statistically different (log-rank=0.9). OS of patients stratified for no postoperative infection or infections by MDS was significantly better than those having MRD/XDR isolates (log-rank=0.04). A Cox multivariate model showed that having MRD/XDR postoperative infections was and independent variable for worse OS (HR=1.227; 95%CI=1.189-1.1918; p=0.036). Conclusion: Postoperative drug resistant infections are a significant risk factor for poor OS after pancreatoduodenectomy for ductal adenocarcinoma.

Original languageEnglish
JournalAnticancer Research
Issue number5
Pages (from-to)2743-2752
Number of pages10
Publication statusPublished - 05.2022

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

DFG Research Classification Scheme

  • 205-25 General and Visceral Surgery

Cite this